戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 tis C virus transmission, all from an active IVDU donor who was hepatitis C virus seronegative at tim
2 V, of whom half had a history of IRB (mostly IVDU [78.5%]).
3 5 kg/m2, low nadir CD4 count, and history of IVDU emerged as possible risk factors for myocardial ste
4  for by depression, fatigue, or a history of IVDU in patients with histologically mild HCV infection.
5                          A history of recent IVDU was associated with fewer potential donors proceedi
6 dent of a history of intravenous drug usage (IVDU), depression, fatigue, or symptom severity.
7 (P = .055), history of intravenous drug use (IVDU) (P = .033), and nadir CD4 count < 350 cells/mm3 (P
8 havior (IRB) including intravenous drug use (IVDU), imprisonment and increased risk sexual behavior.
9 ceived treatment: age; intravenous drug use (IVDU); specific type of sexual contact as risk factors (
10 g among HIV-infected intravenous drug users (IVDUs), we set out to study the effects of smoke exposur
11                   Age greater than 35 years, IVDU, stages III/IV, and CD4 cell counts less than 100/m